CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma

Journal of Neuro-Oncology

Volumn 110, Issue 2, 2012, Pages 179-186

  Xie, You Ke ^a,b   Huo, Shao Fen ^a   Zhang, Gong ^c   Zhang, Fu ^a   Lian, Zu Ping ^b   Tang, Xiong Lin ^d   Jin, Chuan ^e  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b RUIKANG HOSPITAL AFFILIATED TO GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^c SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^d YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITIES   (China)

^e GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

CDA 2; Glioma; miR 124; SLUG; Twist

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; CARBOXYLIC ACID; CELL DIFFERENTIATION AGENT 2; MICRORNA 124; PEPTIDE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; FOCAL ADHESION; GENE CONTROL; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MESENCHYME; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TUMOR DIFFERENTIATION;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTIDINE DEAMINASE; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HUMANS; MICRORNAS; NUCLEAR PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TWIST TRANSCRIPTION FACTOR;

EID: 84867876555     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0961-x     Document Type: Article

References (31)

1. Yao CJ, Lai GM, Chan CF, Yang YY, Liu FC, Chuang SE (2005) Differentiation of pheochromocytoma PC12 cells induced by human urine extract and the involvement of the extracellular signal-regulated kinase signaling pathway. J Altern Complement Med 11:903-908. doi: 10.1089/acm.2005.11.903
2. Xin Y, Xu KS (2001) HPLC determination of peptide's molecular weight in Niaoduosuantai (CDA-II) injection. Chin J Pharm Anal 21:191-193
3. Lu Z, Jia J, Di L, Song G, Yuan Y, Ma B, Yu J, Zhu Y, Wang X, Zhou X, Ren J (2011) DNA methyltransferase inhibitor CDA-2 synergizes with high-dose thiotepa and paclitaxel in killing breast cancer stem cells. Front Biosci 3:240-249. doi: 10.2741/239
4. Wang HY, Zhong XY, Tu YS, Liu ZZ (2006) Effect of CDA-II on the differentiation and inhibition of human glioma cell lines SWO-38. Chin Pharm Bull 22:184-188
5. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996. doi: 10.1016/j.canrad.2005. 07.001
6. Lin CL, Wang MH, Qin YF, Fang M, Xie BB, Zhong XY (2009) Differentiation of SWO-38 glioma cells induced by CDA-2 is mediated by peroxisome proliferator-activated receptor γ. J Neurooncol 95:29-36. doi: 10.1007/s11060-009-9900-x
7. Huang J, Yang M, Liu H, Jin J (2008) Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3 K/Akt signaling pathway in a caspase-3-dependent manner. Acta Pharmacol Sin 29:951-964. doi: 10.1111/j.1745-7254.2008
8. Peinado H, Cano A (2008) A hypoxic twist in metastasis. Nat Cell Biol 10:253-254. doi: 10.1038/ncb0308-253
9. Elias MC, Tozer KR, Silber JR, Mikheeva S, Deng M, Morrison RS, Manning TC, Silbergeld DL, Glackin CA, Reh TA, Rostomily RC (2005) TWIST is expressed in human gliomas and promotes invasion. Neoplasia 7:824-837. http://www.ncbi.nlm. nih.gov/pubmed/16229805
10. Ciafreà SA, Galardi S, Mangiola A, Ferracin M, Liu C-G, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351-1358. doi: 10.1016/j.bbrc.2005.07.030
11. Wang T, Zhang L, Shi C, Sun H, Wang J, Li R, Zou Z, Ran X, Su Y (2012) TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cells. Int J Biochem Cell Biol 44:366-376. doi: 10.1016/j.biocel.2011.11.012
12. Bullock MD, Sayan AE, Packham GK, Mirnezami AH (2012) MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol Cell 104:3-12. doi: 10.1111/boc.201100115
13. Peng X, Guo W, Liu T, Wang X, Tu X, Xiong D, Chen S, Lai Y, Du H, Chen G, Liu G, Tang Y, Huang S, Zou X (2011) Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS ONE 6:e20341. doi: 10.1371/journal.pone.0020341
14. Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245-5250. doi: 10.1158/0008-5472.CAN-04- 0496
15. Velpula KK, Dasari VR, Tsung AJ, Dinh DH, Rao JS (2011) Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist. Oncotarget 2:1028-1042
16. Uziel T, Karginov FV, Xie S, Parker JS, Wang YD, Gajjar A, He L, Ellison D, Gilbertson RJ, Hannon G, Roussel MF (2009) The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci USA 106:2812-2817. doi: 10.1073/pnas.0809579106
17. Brabletz T (2012) MiR-34 and SNAIL: Another double-negative feedback loop controlling cellular plasticity/EMT governed by p53. Cell Cycle 11:215. doi: 10.4161/cc.11.2.18900
18. Yang G, Zhang R, Chen X, Mu Y, Ai J, Shi C, Liu Y, Shi C, Sun L, Rainov NG, Li H, Yang B, Zhao S (2011) MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med (Berl) 89:1037-1050. doi: 10.1007/s00109-011-0775-x
19. Xia H, Cheung WK, Ng SS, Jiang X, Jiang S, Sze J, Leung GK, Gang L, Chan DT, Bian XW, Kung HF, Poon WS, Lin MC (2012) Loss of brain-enriched miR-124 enhances the stem-like traits and invasiveness of glioma cells. J Biol Chem 17:1-18. doi: 10.1074/jbc. M111. 332627
20. Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe CJ, Yang J (2011) SLUG is an essential mediator of Twist-induced epithelial mesenchymal transition and metastasis. Cancer Res 71:245-254. doi: 10.1158/0008-5472.CAN-10-2330
21. Mikheeva SA, Mikheev AM, Petit A, Beyer R, Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H, González-Herrero I, Sánchez-García I, Silber JR, Horner PJ, Rostomily RC (2010) TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer 9:194. http://www.molecular-cancer.com/content/9/1/194
22. Cheng L-C, Pastrana E, Tavazoie M, Doetsch F (2009) miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 12:399-408. doi: 10.1038/nn.2294
23. Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, Li Y, Lee-Messer C, Dolmetsch RE, Tsien RW, Crabtree GR (2011) MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 476:228-231. doi: 10.1038/nature10323
24. Li KK, Pang JC, Ching AK, Wong CK, Kong X, Wang Y, Zhou L, Chen Z, Ng HK (2009) miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40:1234-1243. doi: 10.1016/j.humpath.2009.02. 003
25. Pierson J, Hostager B, Fan R, Vibhakar R (2008) Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol l90:1-7. doi: 10.1007/s11060-008-9624-3
26. Furuta M, Kozaki K, Tanaka S, Arii S, Imoto I, Inazawa J (2010) miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepato- cellular carcinoma. Carcinogenesis 31:766-776. doi: 10.1093/carcin/bgp250
27. Xia J, Wu Z, Yu C, He W, Zheng H, He Y, Jian W, Chen L, Zhang L, Li W (2012) miR-124 inhibits cell proliferation in gastric cancer through downregulation of SPHK1. J Pathol 227:470-480. doi: 10.1002/path.4030
28. Laine S, Alm J, Virtanen S, Aro H, Laitala-Leinonen T (2012) MicroRNAs miR-96, miR-124 and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. J Cell Biochem 133:2687-2695. doi: 10.1002/jcb.24144
29. Zhou Y, Chen KS, Gao JB, Han R, Lu JJ, Peng T, Jia YJ (2012) miR-124-1 promotes neural differentiation of rat bone marrow mesenchymal stem cells. Zhong guo Dang Dai Er Ke Za Zhi 14: 215-220. http://www.cjcp.org/EN/Y2012/V14/I3/215
30. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126:1203-1217. doi: 10.1016/j.cell.2006.07.031
31. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455:1124-1128. doi: 10.1038/nature07299